Table 7.
The association between cognitive performance and total VB2 intake stratified by BMI group
| Cognitive tests | OR1 | 95% CI1 | P1 |
|---|---|---|---|
| CERAD Delayed Recall | |||
| Underweight (< 18.5) | - | – | – |
| Normal (18.5–25) | 1.01 | 0.99, 1.02 | 0.468 |
| Overweight (25–30) | 1.01 | 0.98, 1.03 | 0.601 |
| Obese (≥ 30) | 0.99 | 0.97, 1.01 | 0.283 |
| CERAD Trial 1 Recall | |||
| Underweight (< 18.5) | – | – | – |
| Normal (18.5–25) | 1.02 | 1.00, 1.03 | 0.028 |
| Overweight (25–30) | 1.01 | 0.98, 1.03 | 0.526 |
| Obese (≥ 30) | 1.00 | 0.98, 1.02 | 0.965 |
| CERAD Trial 2 Recall | |||
| Underweight (< 18.5) | – | – | – |
| Normal (18.5–25) | 1.02 | 1.00, 1.03 | 0.029 |
| Overweight (25–30) | 1.01 | 0.99, 1.02 | 0.347 |
| Obese (≥ 30) | 1.01 | 1.00, 1.02 | 0.117 |
| CERAD Trial 3 Recall | |||
| Underweight (< 18.5) | – | – | – |
| Normal (18.5–25) | 1.01 | 1.00, 1.02 | 0.003 |
| Overweight (25–30) | 1.01 | 1.00, 1.02 | 0.027 |
| Obese (≥ 30) | 1.00 | 0.98, 1.01 | 0.502 |
| CERAD total | |||
| Underweight (< 18.5) | – | – | – |
| Normal (18.5–25) | 1.04 | 1.01, 1.07 | 0.005 |
| Overweight (25–30) | 1.03 | 0.98, 1.07 | 0.242 |
| Obese (≥ 30) | 1.00 | 0.97, 1.04 | 0.758 |
| AFT | |||
| Underweight (< 18.5) | – | – | – |
| Normal (18.5–25) | 1.00 | 0.97, 1.03 | 0.805 |
| Overweight (25–30) | 1.03 | 0.98, 1.07 | 0.254 |
| Obese (≥ 30) | 0.96 | 0.93, 0.99 | 0.006 |
| DSST | |||
| Underweight (< 18.5) | – | – | – |
| Normal (18.5–25) | 1.01 | 0.91, 1.13 | 0.834 |
| Overweight (25–30) | 1.03 | 0.93, 1.15 | 0.529 |
| Obese (≥ 30) | 1.04 | 0.95, 1.14 | 0.382 |
1adjusted for age, gender, PIR, race, alcohol intake, and smoking status